Arizona State University has announced the appointment of Jeffrey Kordower as the founding director of the ASU-Banner Neurodegenerative Disease Research Center and endowed chair as The Charlene and J. Orin Edson Distinguished Director at the Biodesign Institute.Continue reading
Category Archives: AZBio News
FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine
-
Action Advances Fight Against COVID-19, Follows Comprehensive Evaluation of Available Safety, Effectiveness and Manufacturing Quality Information by FDA Career Scientists, Input from External Experts
C-Path and Global Partners Launch Ataxia Consortium
The Critical Path to Therapeutics for the Ataxias will optimize clinical trials for inherited ataxias
TUCSON, Ariz., February 26, 2021 — Critical Path Institute (C-Path) today announced the launch of the Critical Path to Therapeutics for the Ataxias (CPTA) Consortium, a public-private partnership focused on optimizing clinical trials for inherited ataxias. CPTA is a collaborative effort between C-Path, Ataxia Global Initiative, the National Ataxia Foundation, Ataxia UK and key partners in the industry and academic research communities, including Biohaven Pharmaceuticals, Ionis Pharmaceuticals, Roche Pharmaceuticals, Servier Group, Triplet Therapeutics, uniQure, and Vico Therapeutics.Continue reading
HTG Concludes Feasibility Testing & Releases Second White Paper for its Planned Whole Transcriptome Panel Using HTG EdgeSeq Technology
TUCSON, Ariz., Feb. 26, 2021 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has completed its feasibility testing for a planned whole transcriptome panel using the HTG EdgeSeq technology, and has released a follow-on whole transcriptome product white paper (White Paper Two), regarding the performance of a prototype panel for multiple cancer indications compared to RNA sequencing (RNA-Seq). HTG is developing a whole transcriptome panel using the HTG EdgeSeq technology to measure approximately 20,000 mRNA targets, with a planned research use only launch in the third quarter of 2021.Continue reading
Seven Arizona bio startups earn $30K through Flinn entrepreneurship program
Five Phoenix, two Tucson firms to receive personalized learning plan, other benefitsContinue reading
VectorCare and Life365 align to expand and accelerate the deployment of digital health solutions for healthcare organizations
The joint partnership between Life365 and VectorCare will enable healthcare organizations to create more efficient workflows and accelerate the deployment of digital health solutions. The companies saw an opportunity to provide remote health monitoring services to effectively treat and manage patients in their homes.
TGen-Led Study Confirms Cell-Free DNA in Urine as Potential Method for Cancer Detection
If successful, non-invasive method could transform detection and treatment outcomesContinue reading
Exact Sciences to Acquire Ashion Analytics and Enter Research Collaboration with City of Hope’s Genomic Institute, TGen
Provides Access to Industry-Leading Sequencing Lab and Plans for 10-Year Partnership with National Cancer Research Leaders
COVID ‘Time Zero’ tool tracks transmission
The Centers for Disease Control originally identified COVID-19’s first arrival in the United States as Jan. 20, 2020, with the first related death occurring on Feb. 29. But on April 29 last year, California reported its first COVID-19-related death had actually occurred three weeks earlier, on Feb. 6, calling the entire timeline into question.
Arizona Board of Regents announces José Luis Cruz as Northern Arizona University presidential finalist
The Arizona Board of Regents announced today that José Luis Cruz, Ph.D. is the finalist for the position of the 17th president of Northern Arizona University.Continue reading